Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Nuclear Magnetic Resonance Spectroscopy Market

ID: MRFR/HC/10632-HCR
128 Pages
Rahul Gotadki
Last Updated: May 15, 2026
Nuclear Magnetic Resonance Spectroscopy Market Research Report Information By Product (Instruments and Consumables), By Type (Low-field NMR Spectroscopy and High-field NMR Spectroscopy), By End-use (Academic, Pharmaceutical & Biotech Companies, Agriculture & Food, Chemical Industry and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Product (USD Billion)
      1. 4.1.1 Instruments
      2. 4.1.2 Consumables
    2. 4.2 Healthcare, BY Type (USD Billion)
      1. 4.2.1 Low-field NMR Spectroscopy
      2. 4.2.2 High-field NMR Spectroscopy
    3. 4.3 Healthcare, BY End-use (USD Billion)
      1. 4.3.1 Academic
      2. 4.3.2 Pharmaceutical & Biotech Companies
      3. 4.3.3 Agriculture & Food
      4. 4.3.4 Chemical Industry
      5. 4.3.5 Others
    4. 4.4 Healthcare, BY Region (USD Billion)
      1. 4.4.1 North America
        1. 4.4.1.1 US
        2. 4.4.1.2 Canada
      2. 4.4.2 Europe
        1. 4.4.2.1 Germany
        2. 4.4.2.2 UK
        3. 4.4.2.3 France
        4. 4.4.2.4 Russia
        5. 4.4.2.5 Italy
        6. 4.4.2.6 Spain
        7. 4.4.2.7 Rest of Europe
      3. 4.4.3 APAC
        1. 4.4.3.1 China
        2. 4.4.3.2 India
        3. 4.4.3.3 Japan
        4. 4.4.3.4 South Korea
        5. 4.4.3.5 Malaysia
        6. 4.4.3.6 Thailand
        7. 4.4.3.7 Indonesia
        8. 4.4.3.8 Rest of APAC
      4. 4.4.4 South America
        1. 4.4.4.1 Brazil
        2. 4.4.4.2 Mexico
        3. 4.4.4.3 Argentina
        4. 4.4.4.4 Rest of South America
      5. 4.4.5 MEA
        1. 4.4.5.1 GCC Countries
        2. 4.4.5.2 South Africa
        3. 4.4.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Bruker Corporation (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Thermo Fisher Scientific Inc. (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Agilent Technologies Inc. (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 JEOL Ltd. (JP)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Varian Medical Systems (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Oxford Instruments plc (GB)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Magritek GmbH (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Nanalysis Corp. (CA)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY PRODUCT
    4. 6.4 US MARKET ANALYSIS BY TYPE
    5. 6.5 US MARKET ANALYSIS BY END-USE
    6. 6.6 CANADA MARKET ANALYSIS BY PRODUCT
    7. 6.7 CANADA MARKET ANALYSIS BY TYPE
    8. 6.8 CANADA MARKET ANALYSIS BY END-USE
    9. 6.9 EUROPE MARKET ANALYSIS
    10. 6.10 GERMANY MARKET ANALYSIS BY PRODUCT
    11. 6.11 GERMANY MARKET ANALYSIS BY TYPE
    12. 6.12 GERMANY MARKET ANALYSIS BY END-USE
    13. 6.13 UK MARKET ANALYSIS BY PRODUCT
    14. 6.14 UK MARKET ANALYSIS BY TYPE
    15. 6.15 UK MARKET ANALYSIS BY END-USE
    16. 6.16 FRANCE MARKET ANALYSIS BY PRODUCT
    17. 6.17 FRANCE MARKET ANALYSIS BY TYPE
    18. 6.18 FRANCE MARKET ANALYSIS BY END-USE
    19. 6.19 RUSSIA MARKET ANALYSIS BY PRODUCT
    20. 6.20 RUSSIA MARKET ANALYSIS BY TYPE
    21. 6.21 RUSSIA MARKET ANALYSIS BY END-USE
    22. 6.22 ITALY MARKET ANALYSIS BY PRODUCT
    23. 6.23 ITALY MARKET ANALYSIS BY TYPE
    24. 6.24 ITALY MARKET ANALYSIS BY END-USE
    25. 6.25 SPAIN MARKET ANALYSIS BY PRODUCT
    26. 6.26 SPAIN MARKET ANALYSIS BY TYPE
    27. 6.27 SPAIN MARKET ANALYSIS BY END-USE
    28. 6.28 REST OF EUROPE MARKET ANALYSIS BY PRODUCT
    29. 6.29 REST OF EUROPE MARKET ANALYSIS BY TYPE
    30. 6.30 REST OF EUROPE MARKET ANALYSIS BY END-USE
    31. 6.31 APAC MARKET ANALYSIS
    32. 6.32 CHINA MARKET ANALYSIS BY PRODUCT
    33. 6.33 CHINA MARKET ANALYSIS BY TYPE
    34. 6.34 CHINA MARKET ANALYSIS BY END-USE
    35. 6.35 INDIA MARKET ANALYSIS BY PRODUCT
    36. 6.36 INDIA MARKET ANALYSIS BY TYPE
    37. 6.37 INDIA MARKET ANALYSIS BY END-USE
    38. 6.38 JAPAN MARKET ANALYSIS BY PRODUCT
    39. 6.39 JAPAN MARKET ANALYSIS BY TYPE
    40. 6.40 JAPAN MARKET ANALYSIS BY END-USE
    41. 6.41 SOUTH KOREA MARKET ANALYSIS BY PRODUCT
    42. 6.42 SOUTH KOREA MARKET ANALYSIS BY TYPE
    43. 6.43 SOUTH KOREA MARKET ANALYSIS BY END-USE
    44. 6.44 MALAYSIA MARKET ANALYSIS BY PRODUCT
    45. 6.45 MALAYSIA MARKET ANALYSIS BY TYPE
    46. 6.46 MALAYSIA MARKET ANALYSIS BY END-USE
    47. 6.47 THAILAND MARKET ANALYSIS BY PRODUCT
    48. 6.48 THAILAND MARKET ANALYSIS BY TYPE
    49. 6.49 THAILAND MARKET ANALYSIS BY END-USE
    50. 6.50 INDONESIA MARKET ANALYSIS BY PRODUCT
    51. 6.51 INDONESIA MARKET ANALYSIS BY TYPE
    52. 6.52 INDONESIA MARKET ANALYSIS BY END-USE
    53. 6.53 REST OF APAC MARKET ANALYSIS BY PRODUCT
    54. 6.54 REST OF APAC MARKET ANALYSIS BY TYPE
    55. 6.55 REST OF APAC MARKET ANALYSIS BY END-USE
    56. 6.56 SOUTH AMERICA MARKET ANALYSIS
    57. 6.57 BRAZIL MARKET ANALYSIS BY PRODUCT
    58. 6.58 BRAZIL MARKET ANALYSIS BY TYPE
    59. 6.59 BRAZIL MARKET ANALYSIS BY END-USE
    60. 6.60 MEXICO MARKET ANALYSIS BY PRODUCT
    61. 6.61 MEXICO MARKET ANALYSIS BY TYPE
    62. 6.62 MEXICO MARKET ANALYSIS BY END-USE
    63. 6.63 ARGENTINA MARKET ANALYSIS BY PRODUCT
    64. 6.64 ARGENTINA MARKET ANALYSIS BY TYPE
    65. 6.65 ARGENTINA MARKET ANALYSIS BY END-USE
    66. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
    67. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    68. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
    69. 6.69 MEA MARKET ANALYSIS
    70. 6.70 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT
    71. 6.71 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    72. 6.72 GCC COUNTRIES MARKET ANALYSIS BY END-USE
    73. 6.73 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT
    74. 6.74 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    75. 6.75 SOUTH AFRICA MARKET ANALYSIS BY END-USE
    76. 6.76 REST OF MEA MARKET ANALYSIS BY PRODUCT
    77. 6.77 REST OF MEA MARKET ANALYSIS BY TYPE
    78. 6.78 REST OF MEA MARKET ANALYSIS BY END-USE
    79. 6.79 KEY BUYING CRITERIA OF HEALTHCARE
    80. 6.80 RESEARCH PROCESS OF MRFR
    81. 6.81 DRO ANALYSIS OF HEALTHCARE
    82. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    83. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    84. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
    85. 6.85 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
    86. 6.86 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion)
    87. 6.87 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    88. 6.88 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    89. 6.89 HEALTHCARE, BY END-USE, 2024 (% SHARE)
    90. 6.90 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
    91. 6.91 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.2.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY END-USE, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.3.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.3.3 BY END-USE, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.4.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.4.3 BY END-USE, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.5.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.5.3 BY END-USE, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.6.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.6.3 BY END-USE, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.7.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.7.3 BY END-USE, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.8.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.8.3 BY END-USE, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.9.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.9.3 BY END-USE, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.10.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.10.3 BY END-USE, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.11.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.11.3 BY END-USE, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.12.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.12.3 BY END-USE, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.13.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.13.3 BY END-USE, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.14.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.14.3 BY END-USE, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.15.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.15.3 BY END-USE, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.16.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.16.3 BY END-USE, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.17.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.17.3 BY END-USE, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.18.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.18.3 BY END-USE, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.19.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.19.3 BY END-USE, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.20.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.20.3 BY END-USE, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.21.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.21.3 BY END-USE, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.22.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.22.3 BY END-USE, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.23.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.23.3 BY END-USE, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.24.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.24.3 BY END-USE, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.25.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.25.3 BY END-USE, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.26.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.26.3 BY END-USE, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.27.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.27.3 BY END-USE, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.28.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.28.3 BY END-USE, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.29.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.29.3 BY END-USE, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY PRODUCT, 2025-2035 (USD Billion)
      2. 7.30.2 BY TYPE, 2025-2035 (USD Billion)
      3. 7.30.3 BY END-USE, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Product (USD Billion, 2025-2035)

  • Instruments
  • Consumables

Healthcare By Type (USD Billion, 2025-2035)

  • Low-field NMR Spectroscopy
  • High-field NMR Spectroscopy

Healthcare By End-use (USD Billion, 2025-2035)

  • Academic
  • Pharmaceutical & Biotech Companies
  • Agriculture & Food
  • Chemical Industry
  • Others